Women's Health Initiative, Southeast Region, Winston-Salem, NC, USA OBJECTIVE: This study was conducted to examine the influence of insulin resistance on weight change in postmenopausal women of various ethnic groups. SUBJECTS: Data were obtained from 3389 women (60% White, 20% Black, 12% Hispanic, and 8% Asian/Pacific Islander), ages 50-79, enrolled in either the Women's Health Initiative Clinical trial or Observational Study, whose blood samples were selected randomly from the full cohort of 161 809 women for analyses. MEASUREMENTS: Glucose, insulin, and lipids were measured on fasting serum samples drawn at baseline and after 3 y of follow-up. Weight, height, waist circumference, and blood pressure were measured. Physical activity and energy intake were assessed via questionnaire. Insulin resistance was estimated using the HOMA (homeostasis model) calculation. RESULTS: Average age was 62 y, average BMI (body mass index) was 27.4 kg/m 2 , and average weight change was a gain of 0.4 kg in 3 y. In a multivariate analysis, insulin resistance and insulin concentrations were independent predictors of increases in weight in White women (P ¼ 0.002 and 0.004, respectively) and in the combined group (P ¼ 0.027 and 0.039). For the whole group, after adjustment for other covariates, those in the highest quartile of insulin resistance gained 0.4 kg in 3 y, whereas those in the lowest quartile lost 0.06 kg. Similar trends were found for insulin resistance and weight gain in Hispanic and Asian/Pacific Islander women, but they did not reach statistical significance. In Black women, no relation was seen between either insulin or insulin resistance and weight change. A significant interaction between obesity and insulin resistance was observed (P ¼ 0.002 for White women and 0.032 for the whole group), so that there is weight gain with increasing insulin resistance in the leaner women, but weight loss with increasing insulin resistance in the most obese. CONCLUSION: Insulin resistance appears to be a predictor of weight gain in postmenopausal women, except for the most obese women. The effect is more pronounced in women who have a lower BMI, and the effect was not seen in the Black women who as a group had a higher BMI.
Introduction
Obesity is a major health problem in the United States. Weight gain occurs with age in both genders, and rates of obesity are highest in postmenopausal women. [1] [2] [3] Although energy intake in excess of energy expenditure is the underlying cause of weight gain, genetic and environmental factors influence this energy imbalance. [1] [2] [3] [4] Thus, it is important to better define the risk factors leading to weight gain in various age groups. Considerable research has been focused on the relationship between insulin resistance and weight gain. This focus began with the Neel hypothesis, in which it was proposed that insulin resistance might provide a survival advantage to populations subject to limited availability of food. 4, 5 According to this hypothesis, insulin-resistant individuals living a Westernized lifestyle, with a continual abundance of food, are predisposed to weight gain. The current analysis is intended to explore the hypothesis that insulin resistance predicts weight gain in postmenopausal women of differing ethnic groups. Studies of children 6 and young adults 7, 8 have found an association between insulin resistance, as measured by fasting insulin, and weight gain. In the Normative Aging Study, researchers found that in White adults a higher insulin concentration predicted increases in weight, 9 and in Chinese men, researchers found that higher insulin levels predicted weight gain. 10 Other researchers examining relations between insulin resistance and weight gain in adults, however, have suggested that insulin sensitivity or low insulin levels could predispose people to gain weight. This predisposition was first described in Pima Indian adults 11 and has been observed in Mexican Americans and nonHispanic Whites in the San Antonio 12 and San Luis Valley
Heart studies, 13 in middle-aged Whites and Blacks in the ARIC cohort, 14 and in older Whites in the Rancho Bernardo
Study. 15 Some of these investigators postulated that ethnic differences might exist in the relationship between insulin sensitivity and weight gain, consistent with the known ethnic differences in prevalence rates of insulin resistance. The Women's Health Initiative (WHI) affords an opportunity to examine the influence of insulin resistance on weight gain in a large cohort of postmenopausal women of diverse ethnic groups. 16 In the current analysis, the homeostasis (HOMA) model is used to examine the influence of insulin resistance on weight gain in White, Black, Hispanic, and Asian/Pacific Islander postmenopausal women. The ethnic and geographic diversity and careful characterization of women in the WHI afford an opportunity to assess the relationship between insulin resistance and weight change in a multiethnic group of postmenopausal women.
Materials and methods

Participants
The current analysis was conducted with data from participants enrolled in the WHI Observational Study (OS) and clinical trials of hormone replacement therapy and diet modification; all participants gave informed consent. Institutional review committees from all 40 clinical centers approved the study, and the study conformed to the ethical guidelines of the 1975 declaration of Helsinki. The WHI is a continuing study of major health issues in postmenopausal women. Descriptions of the overall study and experimental designs have been published previously. 17 A total of 161 809 women, ranging in age from 50 to 79 y old, were enrolled in the observational study or one or both of the clinical trials. They were recruited at 40 clinical centers throughout the United States. Exclusion criteria for the observational study included medical or personal conditions that would preclude a 3-y follow-up visit. Additional exclusion criteria for the diet trial included previous diagnosis of breast or colon cancer, current use of oral corticosteroids, gastrointestinal conditions that required a high fiber diet, Type I diabetes, and current consumption of a diet containing less than 32% of energy from fat. Additional exclusion criteria for the hormone trial included an acute cardiovascular event during the previous 6 months, current use of hormone replacement therapy or oral corticosteroids, history of breast cancer, and history of invasive cancer during the past 10 y. For all components, mental illness or other factors that would preclude informed consent also were exclusion criteria.
Sample selection
Six percent of the women enrolled in the hormone replacement therapy (HRT) trial or the dietary trial and 600 women enrolled in the observational study were selected randomly to have their blood samples analyzed for glucose, insulin, lipids, and homeostatic factors. The random sampling procedure was stratified by age, clinical center, and hysterectomy status. A larger proportion of samples from minority women were selected to increase the sample size of Black, Hispanic, and Asian-Pacific women. For the current analysis, women with diabetes, defined as either a prior diagnosis of the disease or fasting blood glucose level greater than or equal to 7.0 mmol/l (126 mg/dl) or those taking oral hypoglycemic agents or insulin, were excluded. Also excluded were women who did not attend the 3-y follow-up visit, those who quit smoking between the baseline and the follow-up visit, those who were diagnosed with cancer between the baseline and the follow-up visit, and participants taking corticosteroids or weight loss medication, such as amphetamines, sibutramine, or orlistat.
Clinical examinations
The baseline exams for the WHI included physical measurements, fasting blood samples, and interviewer and selfadministered questionnaires. Clinical measurements included weight, height, and blood pressure. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared (kg/m 2 ). Waist circumference was determined with the participants standing, with measurement at the natural waist or the narrowest part of the torso. Measurement was made with the participants clothed, but belts or heavy objects were removed from the waist area. Participants were asked to refrain from taking nonsteroidal, anti-inflammatory drugs or aspirin for 48 h prior to their assessment visit. A blood sample was collected after a 12-h fast. Participants also were asked to refrain from vigorous physical activity for at least 12 h before the blood draw and to refrain from smoking for at least 1 h. Aliquots of plasma and serum were isolated from the blood samples and frozen at À701C within 2 h after being drawn. Self-reported questionnaires included assessment of demographic factors, medical and reproductive history, and health habits. Information on the dose of all current medications, including Insulin resistance and weight gain in postmenopausal women BV Howard et al hormones, was ascertained by the interviewers who administered the questionnaires. Use of vitamins and supplements also was assessed. Physical activity was assessed via a standardized questionnaire, and dietary intake was measured using the WHI Food Frequency Questionnaire. 18 Blood specimens were analyzed by medical research laboratory staff (Highland Heights-Kentucky). Glucose was measured using the glucose oxidase method 19, 20 on the Hitachi 747 analyzer; coefficient of variation was less than 2%. Insulin was measured using a step-wise ELISA procedure; coefficient of variation ranged from 3.2 to 9.5%. 21 The HOMA (homeostasis model) was used to estimate insulin sensitivity from fasting insulin and glucose values. 22 This estimate has been found to correlate well with measures of insulin resistance obtained by the euglycemic clamp technique, 23 and is now commonly used in large population studies where metabolic measures are not tenable. Using this model, insulin resistance was calculated as [FI (mIU/ml) * FG (mmol/1)/(0.0555*18)]/22.5.
Statistical analysis
All analyses were restricted to participants in whom baseline blood draws had been analyzed. This restriction resulted in 2031 White, 681 Black, 405 Hispanic, 272 Asian/Pacific Islander, and 61 American Indian women. Analyses were not performed on American Indian women because of the small number available. Distributions for baseline variables by ethnicity are displayed in the form of medians and ranges for continuous variables and frequencies for categorical variables. Associations of median values for each characteristic with ethnicity were tested using Brown-Mood multisample median tests, and associations of categorical variables with ethnicity were tested using w 2 tests. These tests were performed to determine whether the distribution of each characteristic differed across levels of ethnicity. Two multivariate models were developed to examine the separate relationships of fasting insulin (mIU/ml) and insulin resistance (HOMA-IR) with 3-y weight change within each ethnic group and for the group as a whole. Each model was performed on complete case data and adjusted for age at screening, BMI (kg/m 2 ), waist circumference (cm), categories of physical activity, total daily energy intake (kcal), and fasting glucose (mmol/l), as well as for the interaction between BMI and either fasting insulin or HOMA-IR. BMI, waist circumference, energy intake, and fasting insulin or HOMA were not normally distributed and were log-transformed for all multivariate analyses. Least-squares means were computed for weight change from the resultant multivariate models. Distributions of variables prior to restricting the data set were all similar to the complete case.
Results
Metabolic variables for each ethnic group are shown in Age, BMI, glucose and insulin concentrations, and waist circumference all showed significant univariate associations with insulin resistance (data not shown). Final regression models examining factors that predict weight change were run, including either HOMA-IR (see Table 2 ) or insulin concentration (see Table 3 ) for each ethnic group and for the group as a whole. In all models, age was a significant negative predictor of weight gain in each ethnic group. In all models, physical activity and total energy intake showed no meaningful relationships with weight change. Insulin resistance was a significant predictor of weight gain in White women and in the combined group (Table 2) . A similar effect was found for weight gain in White women and in the total group with increasing insulin concentrations ( Table 3 ). The effect of body size on weight gain was dependent on insulin resistance or insulin level, as evidenced by the significant interaction terms for BMI Â IR or BMI Â Insulin observed in White women and in the combined group (Tables 2 and 3 ). The main effect of BMI was not statistically significant in the overall models when including the interaction with insulin resistance or insulin, but it was significant without the interaction term (data not shown). Thus, we included both the main effect and interaction term in the final models to more fully control for the effect of BMI on weight change. In Hispanic and Asian/Pacific Islander women, regression coefficients for insulin or insulin resistance and weight change and the interaction terms with BMI were similar in magnitude to those in White women, but did not reach statistical significance, presumably because of the smaller sample size (Tables 2 and 3 ). On the other hand, in Black women, the coefficients for the relations between IR or insulin and weight change tended to be negative.
To further illustrate the interaction between BMI and insulin resistance, an age-adjusted multivariate model was developed, including the main effect of BMI, and the resulting relation was plotted for various levels of BMI (Figure 1 ) using data from the combined group. Although the main effect of BMI was not significant when including the interaction of BMI with insulin resistance in the overall multivariate model, we again included it in this model to more fully control for the effect of BMI. The results show increasing weight gain with increasing HOMA-IR in the leaner BMI ranges, and weight loss with increasing HOMA-IR in the higher BMI ranges (P for BMI Â IR interaction ¼ 0.006).
Insulin P-values for association of median values with ethnicity were computed from Brown-Mood tests. P-values for categorical variables were computed from w 2 tests. *P-valueo0.01. **P-valueo0.0001.
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To evaluate other possible confounders in this analysis, the analyses were repeated, eliminating those women who were taking antidepressant or thyroid replacement medications, women who were undergoing the low-fat diet intervention, or women who developed CVD or diabetes within the 3-y period; the results were similar. Also, prior estrogen use was not related to weight change (data not shown).
To quantify the magnitude of the impact of insulin resistance on weight change, change in weight was computed by quartiles of HOMA-IR or insulin concentrations (see Table 4 ); this was done only for the whole group and White women, because of the smaller numbers in the other three ethnic groups. After adjustment for covariates, those in the highest quartile of insulin resistance showed approximately 0.4 kg of weight gain over the average 3-y period, while those in the most insulin-sensitive quartile showed weight loss (P for trends ¼ 0.120 and 0.070, respectively).
Discussion
In this cohort of postmenopausal women, those with insulin resistance were more likely to have subsequent weight gain, but there was an interaction between obesity and insulin resistance. Weight gain was more likely in leaner women with increased insulin resistance than in heavier women Multivariate regression models included all tested variables. They also included an indicator variable for the women who were randomized to the intervention group of the WHI diet trial and were adjusted for hormone use. Multivariate regression models included all tested variables. They also included an indicator variable for the women who were randomized to the intervention group of the WHI diet trial and were adjusted for hormone use.
Insulin resistance and weight gain in postmenopausal women BV Howard et al with increased insulin resistance. This trend was not seen in the Black women, whose mean BMI as a group was higher. Some researchers have shown a positive association between insulin resistance or fasting insulin concentrations and weight gain in adults. This includes the analysis of the longitudinal data from the Normative Aging Study; 9 in this cohort ages and BMI were similar to those of the WHI. Hodge et al. 10 showed that in Chinese in Mauritius, insulin resistance predicted weight gain. Further evidence that insulin resistance predicts adiposity was presented by Gould et al, 24 who showed that insulin resistance predicts central adiposity, and by Boyko et al, 25 who found that increases in fasting insulin predicted increases in visceral fat in Japanese men. Studies of children 6, 7, 26 and of young adults in the CARDIA Study 14 also showed that insulin resistance predicted weight gain.
Other researchers, however, in some studies of adults, have reported a significant association between insulin concentrations or insulin resistance and weight loss. Some possible distinguishing features separate the current cohort from those of other studies; most of the others examined younger adults and in some the participants were quite obese. The Black and White adults in the ARIC Study 8 averaged age 54 with a BMI of 27 kg/m 2 . In the study of Pima Indian adults, 11 the average age was 25 y and average BMI was 34. Similarly, in a study of Mexican Americans and non-Hispanic Whites, the individuals ranged from 25 to 64 y, with a median BMI of approximately 26. 12 In the analysis of White adults in the Rancho Bernardo Study, the mean age was similar to women in the WHI and the average baseline BMI was 24.7. The data from our study provide insight concerning the inconsistencies among studies. We found that, although there was no significant interaction of insulin resistance with age, there was one with BMI, so that the effect of insulin resistance on weight gain was more pronounced in leaner women. Also, in most of the previous studies, data on energy intake, physical activity, and education were not available. Ethnic diversity has been invoked in several earlier studies to explain the inconsistencies in findings. 27 The current data indicate that insulin resistance appears to be greater in Hispanic and African American women compared with White women. 27 In Hispanic and Asian/Pacific Islander women, trends were found between insulin resistance and weight change, which did not reach statistical significance.
On the other hand, there appeared to be no relation between insulin resistance and weight change in the Black women in this study. This possible ethnic difference may be related to the higher BMI of Black women (average of 31). However, Insulin resistance and weight gain in postmenopausal women BV Howard et al the relatively small number and nonrandom selection of subjects make the observation tenuous; more studies of insulin resistance and weight are needed in diverse population groups of all ages. Insulin resistance often is related to increases in visceral adiposity, which is commonly observed with aging. 28 In this study, however, waist circumference was not shown to be a correlate of weight gain or a significant predictor in the multivariate analysis. Adjusting for baseline waist circumference had no effect on the relationship between insulin resistance and weight gain.
Although it is established that obesity and insulin resistance are associated, the causative relationship between insulin resistance and obesity has been debated. Explanations of the Neel hypothesis 4 focus on the concept that resistance to insulin-mediated glucose disposal in peripheral tissues, such as muscle, would lead to energy deposition in adipose tissue. More recently, it has been proposed 29 that
insulin acts in the brain to provide feedback inhibition of food intake, and that insulin resistance in the central nervous system might promote increased energy intake and storage. 30 If this latter construct is operative, then in individuals who are not already overweight, peripheral insulin resistance could be expected to promote weight gain.
On the other hand, in obese individuals, the effect of insulin resistance may be blunted in some way. Another hypothesis that must be considered in evaluating the current observations of the association between insulin resistance and weight gain concerns the role of inflammation. A recent report 31 shows that fibrinogen, white blood cell count, factor VIII, and Von Willebrand factor all are positive predictors of weight gain in middle age adults. All of these inflammatory markers are known to be elevated in insulin resistance. Thus, chronic inflammation, which increases with age, may lead to insulin resistance and weight gain in postmenopausal women. The observation that the effect of insulin resistance is more pronounced in lean individuals may suggest that inflammatory mediators produced by adipocytes may in part mediate the relationship. A number of potential biases must be considered in this analysis. There were a number of medications that could confound the analysis of changes in weight. Women who were on corticosteroids were eliminated from the analysis. The analysis was repeated after eliminating women on thyroid medication or antidepressants, but those changes did not influence the conclusions. Women who developed diabetes during the 3-y follow-up also were eliminated, with no effect on the results. A few women reported smoking cessation between baseline and 3-y follow-up, and these women also were dropped from the analysis. Some controversy exists about the role of postmenopausal estrogen use and weight change in women; however, estrogen use had no effect in our analysis.
Finally, no significant relationships were observed between either energy intake or physical activity and weight change. Self-reported data on both of these parameters are imprecise.
Given that the average weight change during 3 y was small in most cases, it is possible that neither of these measures has the precision to detect the small amount of energy or physical activity imbalance that would be responsible for the average weight changes.
In conclusion, overweight and obesity are major health problems in postmenopausal women. In this cohort of women averaging 62 y of age, slight increases were found in weight on average during a 3-y period. Over a wide range of insulin resistance, insulin resistance appeared to be a predictor of weight gain in White women, with a similar trend in Hispanic and Asian/Pacific Islander women. This effect was more pronounced in leaner women, and was not observed in Black women. All women with high levels of insulin resistance, because they are at risk for the metabolic syndrome and diabetes, should receive increased encouragement to implement lifestyle changes to maintain or reduce insulin resistance.
